IRs like Programmed Death-1 (PD-1) and Cytotoxic T-lymphocyte associated protein 4 (CTLA-4) have been utilized for cancer treatment using inhibitory monoclonal antibodies (mAbs) (7). The gene discussed is CTLA4; the disease is cancer.